Serum chromogranin A in the control of patients on long-term treatment with inhibitors of acid secretion.
Waldum
H L
HL
Department of Intra-abdominal Diseases, University Hospital of Trondheim, Trondheim, Norway. berit.myren@medisin.ntnu.no
Syversen
U
U
D000897:Anti-Ulcer Agents / Q000009:adverse effects*; D015415:Biomarkers; D053379:Chromogranin A; D002864:Chromogranins / Q000097:blood*; D005744:Gastric Acid / Q000378:metabolism; D006801:Humans; D006965:Hyperplasia; D013272:Stomach Diseases / Q000097:blood* / Q000188:drug therapy* / Q000473:pathology
D000897:Anti-Ulcer Agents; D015415:Biomarkers; C506150:CHGA protein, human; D053379:Chromogranin A; D002864:Chromogranins